Showing results (381-390 of 428) with videos related to

Sort By:
Pageof 43
Clinical Radiology|March 1, 1993
The prevalence of paranasal sinus disease in HIV infection and AIDS on cranial MR imagingW K Chong, M A Hall-Craggs, I D Wilkinson, et al.
Pharmaceutical Research|August 1, 1997
Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphyJ Brown, G Hooper, C J Kenyon, et al.
European Journal of Biochemistry|September 24, 1998
Modified glycosylation of cellobiohydrolase I from a high cellulase-producing mutant strain of Trichoderma reeseiM J Harrison, A S Nouwens, D R Jardine, et al.
Annals of the Rheumatic Diseases|April 4, 2008
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics RegisterM J Harrison, W G Dixon, K D Watson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 13, 2014
Inhaled versus nebulised tobramycin: a real world comparison in adult cystic fibrosis (CF)M J Harrison, M McCarthy, C Fleming, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1989
Retinal microembolism and neuropsychological deficit following clinical cardiopulmonary bypass: comparison of a membrane and a bubble oxygenator. A preliminary communicationC Blauth, P Smith, S Newman, et al.
Respiratory Research|March 15, 2022
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelinesMichelle Brennan, M J McDonnell, M J Harrison, et al.
BMC Nephrology|January 5, 2019
The combined diabetes and renal control trial (C-DIRECT) - a feasibility randomised controlled trial to evaluate outcomes in multi-morbid patients with diabetes and on dialysis using a mixed methods approachK Griva, M Rajeswari, M Nandakumar, et al.
British Journal of Cancer|October 9, 2008
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancerM F C Parsons, P A Foster, S K Chander, et al.
British Journal of Cancer|January 22, 2009
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposureJ M Day, P A Foster, H J Tutill, et al.
Pageof 43